2017-12-01 · Notice · 2017-25920
Barr Laboratories, Inc. et al.; Withdrawal of Approval of 68 Abbreviated New Drug Applications
Octreotide
Open attributed record →Federal Register publication year
2017 FDA Federal Register peptide records
5 documents attributed to FDA and HHS and published in 2017, connected only through exact reviewed peptide-name matches.
2017-10-03 · Notice · 2017-21176
Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments
Semaglutide
Open attributed record →2017-10-03 · Notice · 2017-21202
Abbreviated New Drug Applications for Certain Highly Purified Synthetic Peptide Drug Products That Refer to Listed Drugs of Recombinant Deoxyribonucleic Acid Origin; Draft Guidance for Industry; Availability
Glucagon + Liraglutide + Teriparatide
Open attributed record →2017-06-21 · Notice · 2017-12908
Wyeth Pharmaceuticals Inc. et al.; Withdrawal of Approval of 121 New Drug Applications and 161 Abbreviated New Drug Applications
Leuprolide + Octreotide
Open attributed record →2017-05-22 · Notice · 2017-10326
Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments
Liraglutide
Open attributed record →